Changsha-headquartered pharmaceutical company Hunan Nucien Pharmaceutical Co., Ltd, is targeting an initial public offering (IPO) on China’s Nasdaq-like STAR Market to raise about 1.2 billion yuan ($175 million).
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
